Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma

Affiliations

• ¹ Department of Oncology, University Children's Hospital, Zurich, Switzerland.
• ² Functional Genomics Center Zurich, UZH/ETH, Zurich, Switzerland.
• ³ Division of Hematology/Oncology, University Children's Hospital Essen, Essen, Germany.
• ⁴ Department Tumor Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁵ Section of Molecular Pathology, International Agency for Research on Cancer, World Health Organization, Lyon, France.
• ⁶ Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
• ⁷ Institute of Neurology (Edinger Institute) Goethe-University Frankfurt, Frankfurt/Main, Germany.
• ⁸ Department Radiation Oncology, University Hospital, Zurich, Switzerland.
• ⁹ Division of Pediatric Hematology/Oncology, Department of Clinical Research, University of Bern, Bern, Switzerland.
• ¹⁰ Department of Oncology, University Children's Hospital, Zurich, Switzerland. Michael.Grotzer@kispi.uzh.ch.